The Food and Drug Administration has approved the first pill to treat multiple sclerosis.
Gilenya helps reduce MS relapses.
The new drug comes with possible side effects, including the risk of sudden heart irregularities.
Patients are advised to take their first dose under a doctor's supervision.
Until now, injections were the only treatment option for MS patients.